Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study-Reference-Cited by-同舟云学术

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study

Published:2016-10-21 Issue:1 Volume:16 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Schnippel Kathryn^ORCID,Berhanu Rebecca H.,Black Andrew,Firnhaber Cynthia,Maitisa Norah,Evans Denise,Sinanovic Edina

Funder

United States Agency for International Development

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-1933-0.pdf

Reference28 articles.

1. World Health Organization (WHO). Global tuberculosis report. Geneva: World Health Organization; 2015.

2. Statistics South Africa. Mortality and causes of death in South Africa, 2014: Findings from death notification. Pretoria: Statistics South Africa; 2015. www.statssa.gov.za . doi: Statistical release P0309.3.

3. World Health Organization (WHO). Definitions and reporting framework for tuberculosis–2013 revision. 2013.

4. Directorate Drug-Resistant TB. Management of drug-resistant TB: policy guidelines. Pretoria: National Department of Health; 2013. doi: 10.5772/56396 .

5. World Health Organization (WHO). A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis: enhancing the safety of the TB patient. 2012.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical assessment of infants born to mothers with drug resistant tuberculosis;eClinicalMedicine;2024-10

2. Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes;PLOS Global Public Health;2024-05-06

3. Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa;The International Journal of Tuberculosis and Lung Disease;2024-01-01

4. Evaluation of drug-resistant tuberculosis treatment outcome in Limpopo province, South Africa;African Journal of Primary Health Care & Family Medicine;2023-07-31

5. Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®);Antibiotics;2023-04-25